Davenport & CO LLC Stryker Corp Transaction History

Davenport & CO LLC

$17.6 Billion
Q4 2025

A detailed history of Davenport & CO LLC transactions in Stryker Corp stock. As of the latest transaction made, Davenport & CO LLC holds 30,149 shares of SYK stock, worth $10.9 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

30,149

Previous 25,253 19.39%

Holding current value

$10.9 Million

Previous $9.34 Million 16.3%

% of portfolio

0.06%

Previous 0.05%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 12, 2026	BUY	$353.81 - $388.35 $1.73 Million - $1.9 Million	4,896 Added 19.39%	30,149 $10.9 Million
Q3 2025 Oct 15, 2025	BUY	$368.57 - $403.53 $321,393 - $351,878	872 Added 3.58%	25,253 $9.34 Million
Q2 2025 Jul 22, 2025	BUY	$337.37 - $395.63 $151,816 - $178,033	450 Added 1.88%	24,381 $9.65 Million
Q1 2025 Apr 28, 2025	BUY	$355.18 - $399.9 $244,008 - $274,731	687 Added 2.96%	23,931 $8.91 Million
Q4 2024 Jan 24, 2025	BUY	$345.14 - $392.15 $2.45 Million - $2.78 Million	7,086 Added 43.85%	23,244 $8.37 Million

Q3 2024 Oct 24, 2024	BUY	$315.94 - $371.96 $417,356 - $491,359	1,321 Added 8.9%	16,158 $5.84 Million
Q2 2024 Aug 06, 2024	BUY	$324.3 - $354.67 $132,963 - $145,414	410 Added 2.84%	14,837 $5.05 Million
Q1 2024 May 03, 2024	BUY	$293.94 - $358.71 $229,861 - $280,511	782 Added 5.73%	14,427 $5.16 Million
Q4 2023 Jan 23, 2024	BUY	$253.85 - $299.46 $109,409 - $129,067	431 Added 3.26%	13,645 $4.09 Million
Q3 2023 Oct 17, 2023	BUY	$266.54 - $302.43 $171,118 - $194,160	642 Added 5.11%	13,214 $3.61 Million
Q2 2023 Jul 20, 2023	BUY	$271.49 - $305.09 $326,873 - $367,328	1,204 Added 10.59%	12,572 $3.84 Million
Q1 2023 Apr 27, 2023	BUY	$246.13 - $285.47 $49,964 - $57,950	203 Added 1.82%	11,368 $3.25 Million
Q4 2022 Jan 20, 2023	BUY	$205.51 - $253.93 $50,144 - $61,958	244 Added 2.23%	11,165 $0
Q3 2022 Oct 11, 2022	BUY	$189.27 - $231.83 $197,408 - $241,798	1,043 Added 10.56%	10,921 $2.21 Million
Q2 2022 Jul 18, 2022	SELL	$194.09 - $276.37 $42,311 - $60,248	-218 Reduced 2.16%	9,878 $1.97 Million
Q1 2022 May 02, 2022	SELL	$245.33 - $277.77 $26,004 - $29,443	-106 Reduced 1.04%	10,096 $2.7 Million
Q4 2021 Feb 10, 2022	BUY	$236.63 - $276.44 $86,843 - $101,453	367 Added 3.73%	10,202 $2.73 Million
Q3 2021 Oct 14, 2021	BUY	$248.9 - $280.09 $305,649 - $343,950	1,228 Added 14.27%	9,835 $2.59 Million
Q2 2021 Jul 28, 2021	BUY	$242.95 - $267.0 $234,689 - $257,922	966 Added 12.64%	8,607 $2.24 Million
Q1 2021 Apr 28, 2021	BUY	$221.01 - $248.82 $14,365 - $16,173	65 Added 0.86%	7,641 $1.86 Million
Q4 2020 Jan 13, 2021	SELL	$202.01 - $245.04 $2,626 - $3,185	-13 Reduced 0.17%	7,576 $1.86 Million
Q3 2020 Oct 15, 2020	BUY	$177.77 - $215.81 $2,666 - $3,237	15 Added 0.2%	7,589 $1.58 Million
Q2 2020 Jul 28, 2020	BUY	$144.67 - $207.03 $462,509 - $661,874	3,197 Added 73.04%	7,574 $1.37 Million
Q1 2020 May 05, 2020	SELL	$126.5 - $225.1 $43,010 - $76,534	-340 Reduced 7.21%	4,377 $729,000
Q4 2019 Jan 22, 2020	BUY	$197.98 - $220.53 $78,994 - $87,991	399 Added 9.24%	4,717 $990,000
Q2 2019 Jul 10, 2019	SELL	$180.24 - $205.58 $8,831 - $10,073	-49 Reduced 1.12%	4,318 $888,000
Q1 2019 Apr 17, 2019	BUY	$152.46 - $198.0 $4,116 - $5,346	27 Added 0.62%	4,367 $863,000
Q4 2018 Jan 28, 2019	BUY	$145.0 - $178.65 $10,150 - $12,505	70 Added 1.64%	4,340 $680,000
Q3 2018 Oct 11, 2018	SELL	$163.25 - $177.68 $222,836 - $242,533	-1,365 Reduced 24.22%	4,270 $759,000
Q2 2018 Jul 09, 2018	BUY	$155.17 - $179.78 $442,389 - $512,552	2,851 Added 102.41%	5,635 $952,000
Q1 2018 Apr 04, 2018	BUY	$148.01 - $168.91 $155,706 - $177,693	1,052 Added 60.74%	2,784 $448 Million
Q4 2017 Jan 17, 2018	BUY	$143.51 - $159.74 $248,559 - $276,669	1,732	1,732 $268 Million

Others Institutions Holding SYK

# of Institutions

2,586

Shares Held

296M

Call Options Held

1.22M

Put Options Held

948K

View Full List

About STRYKER CORP

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $136B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

More about SYK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.

Account